D. E. Shaw & Co., Inc. Greenwich Life Sciences, Inc. Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$7.14 - $20.36 $125,885 - $358,967	17,631 New	17,631 $149,000
Q1 2022 May 16, 2022	SELL	$16.3 - $24.65 $170,335 - $257,592	-10,450 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$21.76 - $39.43 $227,392 - $412,043	10,450 New	10,450 $254,000

1.1M

Ticker GLSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,848,200
Market Cap $158M
Description
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.